Published in Medical Letter on the CDC and FDA, April 6th, 2008
In October 2007, the Company announced the results of its Phase 1 clinical trial with the Fibrin Patch as an adjunct to hemostasis in 10 patients in Israel. In November 2007,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.